|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to cash provided by (used for) operating activities: | |||||
| Impairment charges | |||||
| Foreign exchange (gain) loss on net debt | |||||
| Bad debt expense | |||||
| Depreciation, depletion and amortization | |||||
| Share-based compensation expense | |||||
| Deferred income tax (benefit) expense | |||||
| Gain on sale of investments and property, plant and equipment | |||||
| Other, net | |||||
| Changes in operating assets and liabilities, excluding the effects of acquisitions: | |||||
| Trade accounts receivable | |||||
| Inventories, including net unrealized mark-to-market gains | |||||
| Secured advances to suppliers | |||||
| Trade accounts payable | |||||
| Trade accounts payable and accrued liabilities | |||||
| Advances on sales | |||||
| Net unrealized (gain) loss on derivative contracts | |||||
| Margin deposits | |||||
| Recoverable and income taxes, net | |||||
| Accrued liabilities | |||||
| Marketable securities | |||||
| Beneficial interest in securitized trade receivables | |||||
| Other, net | |||||
| Cash used for operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Payments made for capital expenditures | |||||
| Acquisitions of businesses (net of cash acquired) | |||||
| Proceeds from investments | |||||
| Payments for investments | |||||
| Settlements of net investment hedges | |||||
| Proceeds from interest in securitized trade receivables | |||||
| Payments for beneficial interest in securitized trade receivables | |||||
| Proceeds from divestiture of business and disposal of property, plant and equipment | |||||
| Payments for investments in affiliates | |||||
| Proceeds from sale of investments in affiliates | |||||
| Other, net | |||||
| Cash provided by investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Proceeds from short-term debt | |||||
| Repayments of short-term debt | |||||
| Proceeds from long-term debt | |||||
| Repayments of long-term debt | |||||
| Proceeds from the exercise of options for common shares | |||||
| Repurchases of common shares | |||||
| Dividends paid to preference shareholders | |||||
| Dividends paid to common shareholders | |||||
| Dividends paid to noncontrolling interests | |||||
| Capital contributions (return of capital) from noncontrolling interests, net | |||||
| Sale of noncontrolling interest | |||||
| Acquisition of redeemable noncontrolling interest and noncontrolling interest | |||||
| Other, net | |||||
| Cash (used for) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale | |||||
| Net increase in cash and cash equivalents, restricted cash, and cash held for sale | |||||
| Cash and cash equivalents, restricted cash, and cash held for sale - beginning of period | |||||
| Cash and cash equivalents, restricted cash, and cash held for sale - end of period | |||||
Loading...